Dykan Jeff bought RGNT
July 9, 2026 · Form 4 insider transaction
Dykan Jeff bought 12,500 shares of Regentis Biomaterials Ltd. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
12,500
Price
$0.00
Total value
N/A
InsiderDykan Jeff
Role—
SecurityWarrants to purchase ordinary shares
Transaction codeA: Grant or award
Transaction dateJuly 9, 2026
Filing dateJuly 13, 2026
Shares owned after12,500
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This warrant was approved by the Board of Directors of the Issuer on February 23, 2026, subject to shareholder approval, which was obtained on July 9, 2026.; The warrants are currently exercisable and have a three year term.